Anabolic Steroid / HCG Medicine
Reproductive deficiency treatment drugs Humenotropin 75iu Menotrophin
Price on Request
Extensive Product Profile: Understanding Humenotropin 75iu
Humenotropin 75iu contains highly purified Menotrophin (also known as Human Menopausal Gonadotropin or hMG), which delivers a balanced therapeutic blend of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). Extracted and refined to meet stringent global medical benchmarks, this specialized hormonal therapy is key in advanced reproductive medicine to address complex reproductive deficiencies and support fertility protocols.
1. Clinical Indications & Usage
Female Infertility (Ovulation Induction): Prescribed to stimulate ovarian follicular development in women experiencing anovulatory infertility (irregular or absent ovulation) who have not responded to primary therapies, such as clomiphene citrate.
Assisted Reproductive Technologies (ART): Utilized in specialized fertility protocols—including In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI)—to induce multi-follicular development for optimized egg retrieval.
Male Infertility: Prescribed to correct sperm count and structural quality issues caused by underlying secondary hormone deficiencies, supporting overall reproductive function.
2. Mechanism of Action: How Humenotropin Works
Follicular Growth Stimulation (FSH Action): In women, the FSH component binds directly to follicle-stimulating hormone receptors on the granulosa cells of the ovaries. This drives the recruitment, growth, and anatomical maturation of ovarian follicles containing the eggs.
Hormonal Balancing & Ovulation Support (LH Action): The LH component targets theca cells to support local estrogen synthesis. Once optimal follicular size is reached via ultrasound tracking, a separate hormonal trigger (such as hCG) is introduced to mimic the natural LH surge, releasing a mature egg.
3. Administration and Dosing Guide
Administration Route: Humenotropin 75iu is formulated for Subcutaneous (SC) or Intramuscular (IM) injection only. It must be administered under direct clinical supervision and should never be taken orally.
Preparation Protocol: The lyophilized powder must be carefully reconstituted with the provided sterile solvent immediately prior to use. Any unused portion must be disposed of safely.
Standard Schedule:
Male Protocols: The standard approach involves 75 IU to 150 IU administered 2 to 3 times per week, frequently paired with human chorionic gonadotropin (hCG) injections to maximize overall testicular response.
⚠️ Safety, Side Effects, and Monitoring
Ovarian Hyperstimulation Syndrome (OHSS): Over-stimulation of the ovaries can cause OHSS, a serious medical condition marked by significant ovarian enlargement, severe abdominal pain, bloating, sudden weight gain, and fluid accumulation. Rapid medical evaluation is mandatory if these symptoms arise.
Multiple Pregnancies: Hormonal follicular induction carries a significantly higher rate of multiple gestations (twins, triplets, or more) compared to natural conception.
Regular Clinical Tracking: Patients must undergo frequent monitoring, including pelvic ultrasounds and blood hormone checks, to verify healthy follicular progress and lower systemic risks.
Common Side Effects: Injection site reactions (redness, mild pain, or swelling), transient headaches, abdominal cramping, pelvic discomfort, nausea, and mild fatigue.
📦 Storage and Handling Specifications
Storage Framework: Store un-reconstituted Humenotropin 75iu vials under climate-controlled conditions as directed by the manufacturer packaging—typically in a secure refrigerator between 2°C and 8°C (36°F to 46°F). Avoid freezing.
Environmental Safeguards: Keep the vial kits enclosed within their original outer box to protect the sensitive protein structures from direct light and thermal shifts. Ensure all used needles and administration syringes are discarded immediately into an approved sharps container. Keep strictly out of reach of children and pets.
📄 Regulatory and Clinical Verification Document Pack
Authentic Product Profile Analysis
Verified Batch Origin Dossier
Clinical Quality Evaluation Dossier
PRESCRIPTION MEDICINE IS : YES
Clinical Disclaimer: This comprehensive profile is compiled strictly for educational, scientific, and medical research documentation purposes. Humenotropin 75iu is an advanced hormone therapy available exclusively under specific clinical authorization (PRESCRIPTION MEDICINE IS YES).
📞 Contact Ernest Impex — Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
Humenotropin 75iu contains highly purified Menotrophin (also known as Human Menopausal Gonadotropin or hMG), which delivers a balanced therapeutic blend of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). Extracted and refined to meet stringent global medical benchmarks, this specialized hormonal therapy is key in advanced reproductive medicine to address complex reproductive deficiencies and support fertility protocols.
1. Clinical Indications & Usage
Female Infertility (Ovulation Induction): Prescribed to stimulate ovarian follicular development in women experiencing anovulatory infertility (irregular or absent ovulation) who have not responded to primary therapies, such as clomiphene citrate.
Assisted Reproductive Technologies (ART): Utilized in specialized fertility protocols—including In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI)—to induce multi-follicular development for optimized egg retrieval.
Male Infertility: Prescribed to correct sperm count and structural quality issues caused by underlying secondary hormone deficiencies, supporting overall reproductive function.
2. Mechanism of Action: How Humenotropin Works
Follicular Growth Stimulation (FSH Action): In women, the FSH component binds directly to follicle-stimulating hormone receptors on the granulosa cells of the ovaries. This drives the recruitment, growth, and anatomical maturation of ovarian follicles containing the eggs.
Hormonal Balancing & Ovulation Support (LH Action): The LH component targets theca cells to support local estrogen synthesis. Once optimal follicular size is reached via ultrasound tracking, a separate hormonal trigger (such as hCG) is introduced to mimic the natural LH surge, releasing a mature egg.
3. Administration and Dosing Guide
Administration Route: Humenotropin 75iu is formulated for Subcutaneous (SC) or Intramuscular (IM) injection only. It must be administered under direct clinical supervision and should never be taken orally.
Preparation Protocol: The lyophilized powder must be carefully reconstituted with the provided sterile solvent immediately prior to use. Any unused portion must be disposed of safely.
Standard Schedule:
Male Protocols: The standard approach involves 75 IU to 150 IU administered 2 to 3 times per week, frequently paired with human chorionic gonadotropin (hCG) injections to maximize overall testicular response.
⚠️ Safety, Side Effects, and Monitoring
Ovarian Hyperstimulation Syndrome (OHSS): Over-stimulation of the ovaries can cause OHSS, a serious medical condition marked by significant ovarian enlargement, severe abdominal pain, bloating, sudden weight gain, and fluid accumulation. Rapid medical evaluation is mandatory if these symptoms arise.
Multiple Pregnancies: Hormonal follicular induction carries a significantly higher rate of multiple gestations (twins, triplets, or more) compared to natural conception.
Regular Clinical Tracking: Patients must undergo frequent monitoring, including pelvic ultrasounds and blood hormone checks, to verify healthy follicular progress and lower systemic risks.
Common Side Effects: Injection site reactions (redness, mild pain, or swelling), transient headaches, abdominal cramping, pelvic discomfort, nausea, and mild fatigue.
📦 Storage and Handling Specifications
Storage Framework: Store un-reconstituted Humenotropin 75iu vials under climate-controlled conditions as directed by the manufacturer packaging—typically in a secure refrigerator between 2°C and 8°C (36°F to 46°F). Avoid freezing.
Environmental Safeguards: Keep the vial kits enclosed within their original outer box to protect the sensitive protein structures from direct light and thermal shifts. Ensure all used needles and administration syringes are discarded immediately into an approved sharps container. Keep strictly out of reach of children and pets.
📄 Regulatory and Clinical Verification Document Pack
Authentic Product Profile Analysis
Verified Batch Origin Dossier
Clinical Quality Evaluation Dossier
PRESCRIPTION MEDICINE IS : YES
Clinical Disclaimer: This comprehensive profile is compiled strictly for educational, scientific, and medical research documentation purposes. Humenotropin 75iu is an advanced hormone therapy available exclusively under specific clinical authorization (PRESCRIPTION MEDICINE IS YES).
📞 Contact Ernest Impex — Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
Enquire About This Product
